✦ LIBER ✦

Treatment of tacrolimus-related adverse effects by conversion to cyclosporine in liver transplant recipients

✍ Scribed by S. Emre; Y. Genyk; L. K. Schluger; T. M. Fishbein; S. R. Guy; P. A. Sheiner; M. E. Schwartz; C. M. Miller

Publisher: Springer
Year: 2000
Tongue: English
Weight: 63 KB
Volume: 13
Category: Article
ISSN: 0934-0874
DOI: 10.1007/s001470050012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lipid abnormalities in stable liver tran

Lipid abnormalities in stable liver transplant recipients – effects of cyclosporin, tacrolimus, and steroids

✍ C. Fernández-Miranda; C. Guijarro; A. del Palacio; A. de la Calle; C. Loinaz; I. 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 210 KB

Occurrence of gammopathies and lymphopro

Occurrence of gammopathies and lymphoproliferative disorders in liver transplant recipients randomized to tacrolimus (FK506)- or cyclosporine-based immunosuppression

✍ Pham, Hung ;Lemoine, Antoinette ;Salvucci, Marina ;Azoulay, Daniel ;Frenoy, Nico 📂 Article 📅 1998 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 110 KB

Lymphoproliferative disorders (LPDs) are a serious side effect of immunosuppression after liver transplantation, and the introduction on the market of a new immunosuppressive drug has been associated with an increased risk of these disorders. To compare the effect of cyclosporine A (CSA) and FK506 i

Impact of changing immunosuppressive mon

Impact of changing immunosuppressive monotherapy from Cyclosporin A to Tacrolimus in long-term, stable liver transplant recipients

✍ Rudolf Ott; Michaela Bussenius-Kammerer; Thomas Reck; ChristianA. Koch; Hermann 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 176 KB